- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatitis C Infection in South Africa
Total 3451 results
-
bioLytical LaboratoriesRecruiting
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Kirby InstituteMerck Sharp & Dohme LLC; The University of New South WalesCompletedChronic Hepatitis C InfectionAustralia
-
Kirby InstituteCompleted
-
Kirby InstituteCompleted
-
Kirby InstituteCompleted
-
bioLytical LaboratoriesRecruitingHepatitis B | Hepatitis B InfectionSouth Africa
-
Kirby InstituteCompletedHepatitis C, ChronicAustralia
-
Kirby InstituteJanssen-Cilag Ltd.CompletedHepatitis C, ChronicAustralia
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis CAustralia
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
Kirby InstituteThe University of New South WalesCompleted
-
Gilead SciencesTerminatedChronic Hepatitis CUnited States, Australia, Canada, New Zealand
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Kirby InstituteCompleted
-
Gilead SciencesTerminatedHepatitis C Virus InfectionFrance, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
-
Garvan Institute of Medical ResearchCompleted
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Melbourne HealthHoffmann-La Roche; Monash University; The University of New South Wales; St Vincent... and other collaboratorsCompletedChronic Hepatitis CAustralia
-
Avera McKennan Hospital & University Health CenterWithdrawnChronic Hepatitis CUnited States
-
University of Witwatersrand, South AfricaUnknownMeasles | Hepatitis A | VaricellaSouth Africa
-
GlaxoSmithKlineCompleted
-
Kirby InstituteBristol-Myers SquibbWithdrawnHepatitis C, ChronicAustralia
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
Boehringer IngelheimWithdrawnHepatitis C, ChronicAustralia, Spain, Sweden
-
Gilead SciencesCompletedHepatitis C Virus InfectionGermany, United States, Australia, United Kingdom, Canada, France, New Zealand
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France
-
Janssen Infectious Diseases BVBACompletedHepatitis C Virus InfectionUnited States, Canada
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Italy, United Kingdom, Germany, Belgium, Russian Federation, New Zealand, Australia
-
Atea Pharmaceuticals, Inc.RecruitingHepatitis C | Hepatitis C, Chronic | HCV | Chronic Hepatitis C Virus | Hepatic CirrhosisTurkey, Brazil, Romania, Canada, Philippines, Pakistan, South Africa, Moldova, Republic of, United States, India, Korea, Republic of, Mauritius
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico, New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico, New Zealand
-
Janssen Infectious Diseases BVBACompletedHepatitis C Virus InfectionUnited States, Canada
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, New Zealand, Australia, United Kingdom
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbPharmassetCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, New Zealand, Puerto Rico, Australia
-
Kirby InstituteActive, not recruitingHepatitis C | HIV | HIV-HCV CoinfectionAustralia
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, New Zealand, Canada, Germany, Puerto Rico, United Kingdom, Australia, Italy
-
Kirby InstituteCompletedHepatitis C, ChronicUnited States, United Kingdom, Australia, France, New Zealand, Canada, Switzerland, Germany
-
Bristol-Myers SquibbCompletedHepatitis C Virus InfectionAustralia, France, Germany, Korea, Republic of, Sweden, Taiwan, United Kingdom, United States, Canada, Mexico, Austria, Italy, Spain, Denmark, Argentina, Poland, Ireland, Greece, New Zealand
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Pertussis | Tetanus | Diphtheria | Polio | Human Immunodeficiency Virus InfectionSouth Africa
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, New Zealand, Germany, Australia, Poland